PLoS Pathogens (Jan 2012)

Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).

  • Chae Kim,
  • Tracy Haldiman,
  • Krystyna Surewicz,
  • Yvonne Cohen,
  • Wei Chen,
  • Janis Blevins,
  • Man-Sun Sy,
  • Mark Cohen,
  • Qingzhong Kong,
  • Glenn C Telling,
  • Witold K Surewicz,
  • Jiri G Safar

DOI
https://doi.org/10.1371/journal.ppat.1002835
Journal volume & issue
Vol. 8, no. 8
p. e1002835

Abstract

Read online

The mammalian prions replicate by converting cellular prion protein (PrP(C)) into pathogenic conformational isoform (PrP(Sc)). Variations in prions, which cause different disease phenotypes, are referred to as strains. The mechanism of high-fidelity replication of prion strains in the absence of nucleic acid remains unsolved. We investigated the impact of different conformational characteristics of PrP(Sc) on conversion of PrP(C) in vitro using PrP(Sc) seeds from the most frequent human prion disease worldwide, the Creutzfeldt-Jakob disease (sCJD). The conversion potency of a broad spectrum of distinct sCJD prions was governed by the level, conformation, and stability of small oligomers of the protease-sensitive (s) PrP(Sc). The smallest most potent prions present in sCJD brains were composed only of∼20 monomers of PrP(Sc). The tight correlation between conversion potency of small oligomers of human sPrP(Sc) observed in vitro and duration of the disease suggests that sPrP(Sc) conformers are an important determinant of prion strain characteristics that control the progression rate of the disease.